Hepatology

Clinical evidence, research, and medical intelligence in Hepatology.

Alcohol Use Disorder Raises Liver Cancer and Other Malignancy Risk

Alcohol use disorder and alcohol-associated liver disease increase liver cancer and other malignancy risk, with abstinence offering meaningful protection.

By Dr. A. Nikhil Krishnan, MBBS · Nov 1, 2026 · 5 min read

Hepatology·Front Immunol

Cannabidiol reduces hepatic fibrosis through TRPV4 and macrophage reprogramming

Preclinical study links cannabidiol to lower hepatic fibrosis by suppressing M2-like macrophages through TRPV4/RhoA/ROCK signaling in mice and…

Nov 1, 2026

Hepatology·Front Immunol

Liver Disease Research Advances New Biomarkers and Treatment Paths

Frontiers editorial reviews liver disease biology, from HBV immune escape to PBC ductopenia and emerging biomarker-guided therapies.

Nov 1, 2026

Hepatology·Gut

GDF15 may ease alcohol-associated liver disease by reprogramming neutrophils

Gut study links growth differentiation factor 15 to reduced neutrophil glycolysis, pointing to a new immunometabolic angle in…

Oct 31, 2026

Hepatology·Lancet Onc

Endohepatology may close the portal hypertension gap in MASLD

Endohepatology adds direct pressure, elastographic, and histologic data in MASLD, where obesity weakens noninvasive portal hypertension assessment.

Oct 31, 2026

Hepatology·NIH

Global MASLD burden rose to 1.3 billion cases, with 2050 growth projected

Global analysis estimates 1.3 billion people lived with MASLD in 2023, with cases projected to reach 1.8 billion…

Oct 30, 2026

Hepatology·Nature

HBV and HDV in Mauritania: Genotypes, Coinfection, and Liver Injury

Mauritanian patients with chronic hepatitis B showed frequent HDV coinfection, genotype D dominance, and liver injury linked to…

Oct 30, 2026

Hepatology·NLM

GLP-1 Drugs Linked to Lower Liver and Kidney Risks in Viral Hepatitis

In U.S. claims data, GLP-1 receptor agonists were associated with lower cirrhosis, HCC, and CKD risks in type…

Oct 28, 2026

Hepatology·STAT

Liver Disease Review Maps Plant-Derived Compounds to Hepatoprotection

A 2026 review links ethnopharmacology, liver disease mechanisms, and plant-derived compounds such as silymarin, curcumin, and glycyrrhizin.

Oct 27, 2026

Hepatology·ScienceDaily

Low Testosterone Amplifies Fructose-Driven Fatty Liver in Mice

Mouse data link low testosterone and fructose to worse fatty liver through gut bacteria and intestinal pyruvate, pointing…

Oct 27, 2026

Hepatology

Clinical evidence, research, and medical intelligence in Hepatology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.